Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 6/20/13 → 6/30/17 |
Financiación
- Biotest Pharmaceuticals Corporation: 162.875,00 US$
Biotest 988: A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human) Civacir in Orthotopic Liver Transplant Recipients
- Rosenau, Jens (PI)
- Daily, Michael (CoI)
- Gedaly, Roberto (CoI)
- Rojas, Hender (CoI)
- Shah, Malay (CoI)
- Sitzlar, Stephen (CoI)